Literature DB >> 25630496

Two-part test of vaccine effect.

Zonghui Hu1, Michael Proschan.   

Abstract

Vaccine benefit is usually two-folded: (i) prevent a disease or, failing that, (ii) diminish the severity of a disease. To assess vaccine effect, we propose two adaptive tests. The weighted two-part test is a combination of two statistics, one on disease incidence and one on disease severity. More weight is given to the statistic with the larger a priori effect size, and the weights are determined to maximize testing power. The randomized test applies to the scenario where the total number of infections is relatively small. It uses information on disease severity to bolster power while preserving disease incidence as the primary interest. Properties of the proposed tests are explored asymptotically and by numerical studies. Although motivated by vaccine studies, the proposed tests apply to any trials that involve both binary and continuous outcomes for evaluating treatment effect. Published 2015. This article is a US Government work and is in the public domain in the USA.

Entities:  

Keywords:  Fisher's exact test; Lachenbruch's test; local alternative; randomization test; vaccine

Mesh:

Substances:

Year:  2015        PMID: 25630496      PMCID: PMC4393783          DOI: 10.1002/sim.6412

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  5 in total

1.  Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials.

Authors:  Peter B Gilbert; Ronald J Bosch; Michael G Hudgens
Journal:  Biometrics       Date:  2003-09       Impact factor: 2.571

2.  Analysis of data with excess zeros.

Authors:  Peter A Lachenbruch
Journal:  Stat Methods Med Res       Date:  2002-08       Impact factor: 3.021

3.  Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial.

Authors:  Clayton D Harro; Franklyn N Judson; Geoffrey J Gorse; Kenneth H Mayer; Jay R Kostman; Stephen J Brown; Beryl Koblin; Michael Marmor; Bradford N Bartholow; Vladimir Popovic
Journal:  J Acquir Immune Defic Syndr       Date:  2004-11-01       Impact factor: 3.731

4.  Comparison of models for analyzing two-group, cross-sectional data with a Gaussian outcome subject to a detection limit.

Authors:  Ryan E Wiegand; Charles E Rose; John M Karon
Journal:  Stat Methods Med Res       Date:  2014-05-05       Impact factor: 3.021

5.  Chop-lump tests for vaccine trials.

Authors:  Dean Follmann; Michael P Fay; Michael Proschan
Journal:  Biometrics       Date:  2009-02-05       Impact factor: 2.571

  5 in total
  3 in total

1.  Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat.

Authors:  Sally Hunsberger; Matthew J Memoli
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

2.  Analysis of responder-based endpoints: improving power through utilising continuous components.

Authors:  James Wason; Martina McMenamin; Susanna Dodd
Journal:  Trials       Date:  2020-05-25       Impact factor: 2.279

3.  Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach.

Authors:  Julianne Duhazé; Miguel Caubet; Signe Hässler; Delphine Bachelet; Matthieu Allez; Florian Deisenhammer; Anna Fogdell-Hahn; Aude Gleizes; Salima Hacein-Bey-Abina; Xavier Mariette; Marc Pallardy; Philippe Broët
Journal:  BMC Med Res Methodol       Date:  2020-03-20       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.